Allopurinol是一种口服有效的黄嘌呤氧化酶抑制剂，其半数抑制浓度（IC50）为0.2-50 μM。该化合物可降低低氧诱导因子-1α（HIF-1α）和HIF-2α的蛋白表达水平，并表现出抗抑郁、镇痛及抗利什曼原虫活性，在高尿酸血症和痛风的研究中具有重要应用价值。
| 英文别名 (English Synonym) | Allopurinol |
| 中文名称 (Chinese Name) | 别嘌呤醇；别嘌醇 |
| 靶点 (Target) | XAO |
| 通路 (Pathway) | Others |
| CAS号 (CAS NO.) | 315-30-0 |
| 分子式 (Formula) | C5H4N4O |
| 分子量 (Molecular Weight) | 136.11 |
| 纯度 (Purity) | ≥98% |
| 溶解性 (Solubility) | 溶于DMSO |
-25~-15℃保存，有效期3年
[1] Sun Y, George J, Rocha S. Dose-dependent effects of allopurinol on human foreskin fibroblast cells and human umbilical vein endothelial cells under hypoxia. PLoS One. 2015 Apr 1;10(4):e0123649. doi: 10.1371/journal.pone.0123649. PMID: 25830774; PMCID: PMC4382188. [2] Schmidt AP, Böhmer AE, Antunes C, Schallenberger C, Porciúncula LO, Elisabetsky E, Lara DR, Souza DO. Anti-nociceptive properties of the xanthine oxidase inhibitor allopurinol in mice: role of A1 adenosine receptors. Br J Pharmacol. 2009 Jan;156(1):163-72. doi: 10.1111/j.1476-5381.2008.00025.x. PMID: 19133997; PMCID: PMC2697763.
